Human Toll-like receptor 4 recognizes host-specific LPS modifications
Top Cited Papers
- 25 March 2002
- journal article
- research article
- Published by Springer Nature in Nature Immunology
- Vol. 3 (4), 354-359
- https://doi.org/10.1038/ni777
Abstract
Lipopolysaccharide (LPS) is the principal proinflammatory component of the Gram-negative bacterial envelope and is recognized by the Toll-like receptor 4 (TLR4)-MD-2 receptor complex. Bacteria can alter the acylation state of their LPS in response to environmental changes. One opportunistic bacterium, Pseudomonas aeruginosa, synthesizes more highly acylated ( hexa-acylated) LPS structures during adaptation to the cystic fibrosis airway. Here we show that human, but not murine, TLR4-MD-2 recognizes this adaptation and transmits robust proinflammatory signals in response to hexa-acylated but not penta-acylated LPS from P. aeruginosa. Whereas responses to lipid(IVA) and taxol are dependent on murine MD-2, discrimination of P. aeruginosa LPS structures is mediated by an 82-amino-acid region of human TLR4 that is hypervariable across species. Thus, in contrast to mice, humans use TLR4 to recognize a molecular signature of bacterial-host adaptation to modulate the innate immune response.Keywords
This publication has 35 references indexed in Scilit:
- Lipopolysaccharide Is in Close Proximity to Each of the Proteins in Its Membrane Receptor ComplexJournal of Biological Chemistry, 2001
- Longitudinal Assessment ofPseudomonas aeruginosain Young Children with Cystic FibrosisThe Journal of Infectious Diseases, 2001
- Genetic and Functional Analysis of a PmrA-PmrB-Regulated Locus Necessary for Lipopolysaccharide Modification, Antimicrobial Peptide Resistance, and Oral Virulence of Salmonella enterica Serovar TyphimuriumInfection and Immunity, 2000
- Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharideJournal of Clinical Investigation, 2000
- Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)The Journal of Experimental Medicine, 1999
- The innate immune system in cystic fibrosis lung diseaseJournal of Clinical Investigation, 1999
- DnaSP version 3: an integrated program for molecular population genetics and molecular evolution analysis.Bioinformatics, 1999
- Cystic fibrosis.American Journal of Respiratory and Critical Care Medicine, 1996
- A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.Journal of Clinical Investigation, 1996
- Receptor-Dependent Mechanisms of Cell Stimulation by Bacterial EndotoxinAnnual Review of Immunology, 1995